COMMUNIQUE ISSUED AT THE END OF THE 27TH EMERGENCY TELECONFERENCE MEETING OF THE NIGERIA GOVERNORS’ FORUM (4th IN 2021) HELD ON WEDNESDAY, 4th MARCH 2021.

Please use this identifier to cite or link to this item: http://ngfrepository.org.ng:8080/jspui/handle/123456789/3065

Full metadata record

DC Field	Value	Language
dc.contributor.author	Nigeria Governors' Forum	-
dc.date.accessioned	2021-03-18T14:14:58Z	-
dc.date.available	2021-03-18T14:14:58Z	-
dc.date.issued	2021-03-04	-
dc.identifier.citation	NGF TC Communique (2021) March Meeting	en_US
dc.identifier.uri	http://ngfrepository.org.ng:8080/jspui/handle/123456789/3065	-
dc.description.abstract	The members of the Nigeria Governors’ Forum (NGF) at the emergency meeting, deliberated on the administration of the first batch of the COVAX AstraZeneca COVID-19 vaccine which was received by the government of Nigeria on 2nd March 2021.	en_US
dc.language.iso	en	en_US
dc.publisher	Nigeria Governors' Forum Publishing	en_US
dc.relation.ispartofseries	NGF TELECONFERENCING MEETING;27TH	-
dc.subject	COMMUNIQUE	en_US
dc.subject	NGF MEETING	en_US
dc.subject	GOVERNORS	en_US
dc.subject	TELECONFERENCING	en_US
dc.title	COMMUNIQUE ISSUED AT THE END OF THE 27TH EMERGENCY TELECONFERENCE MEETING OF THE NIGERIA GOVERNORS’ FORUM (4th IN 2021) HELD ON WEDNESDAY, 4th MARCH 2021.	en_US
dc.type	Working Paper	en_US
Appears in Collections:	COMMUNIQUE - NGF TELECONFERENCING MEETINGS 2021

Files in This Item:

File	Description	Size	Format
27th Teleconference Meeting - Communique.pdf	Communique	323.58 kB	Adobe PDF	View/Open